-
Advancing patient-reported outcomes in cancer clinical trials
The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has... Read more -
Myeloid mimicry enables kidney tumors to resist immunotherapy and worsen rapidly, study finds
Researchers at The University of Texas MD Anderson Cancer Center have found that renal medullary carcinoma (RMC) cells use an... Read more -
HER2-targeted therapy shows promising results in rare bile duct cancers
Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according... Read more -
Tattoos could be a risk factor for melanoma
An increasing number of Swedes are getting tattoos and Sweden's population is now one of the most tattooed in Europe.... Read more -
Many men may not need long-term hormone therapy for prostate cancer, study suggests
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of... Read more -
The cancer blood test making waves, and what the numbers really show
Progress in cutting the global toll of cancer remains painfully slow, but a new blood test has sparked unusual levels... Read more -
Scientists develop one-product-fits-all immunotherapy for pancreatic cancer
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout... Read more -
Cracking gastric cancer's metabolic code: Blocking cholesterol pathways slows tumor growth by 65% in mice
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough... Read more -
Much-needed new drug approved for deadliest blood cancer
Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for patients... Read more -
Shapeshifting tumors unmasked: New insights into master regulators reveal therapeutic vulnerabilities
Some tumors are almost impossible to treat. That's especially true for carcinomas, which don't behave like other malignancies. Some of... Read more -
Higher glycemic index linked to higher lung cancer risk
In a study appearing in The Annals of Family Medicine, researchers examined whether people who follow higher-GI or higher-GL diets... Read more -
Focused ultrasound with chemotherapy shows survival benefit for brain cancer patients, clinical trial finds
Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly... Read more -
Study demonstrates proof of concept for preventing esophageal cancer
Trinity St James's Cancer Institute (TSJCI) researchers demonstrated the power of a structured, quality-assured Barrett's Esophagus Registry to prevent and... Read more -
Treatment of multiple myeloma at specialized clinic tied to improved survival
Patients with newly diagnosed multiple myeloma (NDMM) treated at a specialized clinic have improved outcomes, with median overall survival (OS)... Read more -
Why monkey studies may mislead research on cancer immunotherapy drugs targeting TIGIT
A new study published in the Journal of Biological Chemistry from UC Davis Comprehensive Cancer Center finds that TIGIT, an... Read more
